So, above Rs 250 Cr market cap (thats where I like to play mostly), out of 1168 companies:
> 40% correction : 6% companies
> 30% correction : 18% companies
> 20% correction : 45% companies
Not bad. So, almost evey second company is down by 20% from life time high
More from kumar saurabh
At scientific investing, we ve "ghoomega" strategy n currently 4 stocks. UFO was one example shared
The least to do is observe all charts of @VVVStockAnalyst @charts_zone @Accuracy_Invst n u will get their pattern
Many were telling me that's stocks move after my post
— Volatility Volume and Value (@VVVStockAnalyst) April 18, 2022
Didn't post nahar cap today when I bought and now it's 10% higher
This shows we surf the move and don't make the move \u270c\ufe0f
1. Basics of Finance
2. Basics of Valuation
3. Basics of Fraud
Else you are putting your hard earned money on fire. Enough books and free resources available.
Wrote this thread for the same leveraging one of my Youtube videos as friends wanted to know where to
Few friends are asking for list of books to learn investing topics. Have covered from my side a year back in this Youtube videohttps://t.co/bUb2S3eAVm
— kumar saurabh (@suru27) May 12, 2022
Will break down into parts what needs to be read at least as a pure fundamental investor in this thread
You May Also Like
@NBA @StephenKissler @yhgrad 1. From Day 1, SARS-COV-2 was very well adapted to humans .....and transgenic hACE2 Mice
1. From Day 1, SARS-COV-2 was very well adapted to humans .....and transgenic hACE2 Mice
— Billy Bostickson \U0001f3f4\U0001f441&\U0001f441 \U0001f193 (@BillyBostickson) January 30, 2021
"we generated a mouse model expressing hACE2 by using CRISPR/Cas9 knockin technology. In comparison with wild-type C57BL/6 mice, both young & aged hACE2 mice sustained high viral loads... pic.twitter.com/j94XtSkscj
@NBA @StephenKissler @yhgrad 2. High Probability of serial passaging in Transgenic Mice expressing hACE2 in genesis of SARS-COV-2
1. High Probability of serial passaging in Transgenic Mice expressing hACE2 in genesis of SARS-COV-2!
— Billy Bostickson \U0001f3f4\U0001f441&\U0001f441 \U0001f193 (@BillyBostickson) January 2, 2021
2 papers:
Human\u2013viral molecular mimicryhttps://t.co/irfH0Zgrve
Molecular Mimicryhttps://t.co/yLQoUtfS6s https://t.co/lsCv2iMEQz
@NBA @StephenKissler @yhgrad B.1.1.7 has an unusually large number of genetic changes, ... found to date in mouse-adapted SARS-CoV2 and is also seen in ferret infections.
https://t.co/9Z4oJmkcKj

@NBA @StephenKissler @yhgrad We adapted a clinical isolate of SARS-CoV-2 by serial passaging in the ... Thus, this mouse-adapted strain and associated challenge model should be ... (B) SARS-CoV-2 genomic RNA loads in mouse lung homogenates at P0 to P6.
https://t.co/I90OOCJg7o
